10,113 Shares in STERIS plc (NYSE:STE) Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC purchased a new position in STERIS plc (NYSE:STE) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 10,113 shares of the medical equipment provider’s stock, valued at approximately $2,223,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Millburn Ridgefield Corp acquired a new position in STERIS in the 3rd quarter worth approximately $25,000. Catalyst Capital Advisors LLC acquired a new stake in shares of STERIS during the 3rd quarter worth approximately $25,000. 1832 Asset Management L.P. acquired a new stake in shares of STERIS during the 1st quarter worth approximately $25,000. Global Wealth Management Investment Advisory Inc. acquired a new stake in shares of STERIS during the 3rd quarter worth approximately $49,000. Finally, NBC Securities Inc. acquired a new stake in shares of STERIS during the 3rd quarter worth approximately $50,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Down 0.6 %

Shares of NYSE:STE opened at $199.62 on Friday. STERIS plc has a 1 year low of $180.54 and a 1 year high of $254.00. The firm has a market capitalization of $19.72 billion, a price-to-earnings ratio of 34.96 and a beta of 0.79. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The business’s 50 day moving average price is $223.71 and its 200-day moving average price is $217.48.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.17 by $0.05. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.02 EPS. On average, equities research analysts forecast that STERIS plc will post 8.67 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were issued a $0.52 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $2.08 dividend on an annualized basis and a yield of 1.04%. STERIS’s payout ratio is currently 36.43%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. KeyCorp assumed coverage on shares of STERIS in a research note on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price objective on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, April 12th. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 8th. Stephens reiterated an “overweight” rating and set a $250.00 target price on shares of STERIS in a research report on Friday, February 9th. Finally, TheStreet upgraded STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and an average price target of $239.60.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.